Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$3.17M Sell
48,653
-55
-0.1% -$3.46K 0.75% 45
2016
Q4
$3.05M Buy
48,708
+525
+1% +$32K 0.74% 45
2016
Q3
$3.04M Buy
48,183
+1,050
+2% +$68K 0.87% 37
2016
Q2
$2.92M Buy
47,133
+525
+1% +$32K 0.73% 44
2016
Q1
$2.66M Buy
46,608
+2,420
+5% +$135K 0.68% 49
2015
Q4
$2.62M Buy
44,188
+1,675
+4% +$96.5K 0.69% 49
2015
Q3
$2.31M Buy
42,513
+3,205
+8% +$209K 0.65% 50
2015
Q2
$2.64M Sell
39,308
-30
-0.1% -$1.96K 0.69% 47
2015
Q1
$2.3M Buy
39,338
+1,325
+3% +$80K 0.55% 53
2014
Q4
$2.49M Sell
38,013
-200
-0.5% -$12.6K 0.59% 52
2014
Q3
$2.21M Sell
38,213
-200
-0.5% -$11.1K 0.54% 54
2014
Q2
$2.17M Buy
38,413
+400
+1% +$21K 0.55% 53
2014
Q1
$1.95M Sell
38,013
-935
-2% -$47.3K 0.53% 54
2013
Q4
$2.06M Sell
38,948
-750
-2% -$36.9K 0.54% 55
2013
Q3
$1.78M Sell
39,698
-2,020
-5% -$89.5K 0.52% 55
2013
Q2
$1.73M Buy
+41,718
New +$1.82M 0.5% 57

Other funds holding ABBV

Agran Libbie's ABBV Position: Q1 2017 in Review

Agran Libbie reduced its AbbVie (ABBV) stake by 0.11% in Q1 2017, selling an estimated $3.46K and leaving 48,653 shares worth $3.17M. The position accounts for 0.75% of the portfolio, ranked #45.

Agran Libbie first reported a position in ABBV in Q2 2013 and has held it in 16 quarters since. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Agran Libbie held 48,653 shares of AbbVie worth $3.17M as of Q1 2017.
  • Agran Libbie sold 55 AbbVie shares in Q1 2017, an estimated $3.46K.
  • AbbVie made up 0.75% of Agran Libbie's portfolio in Q1 2017, its #45 holding.
  • Agran Libbie first reported a position in AbbVie in Q2 2013 and has held it in 16 quarters since.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Agran Libbie's 13F filing for Q1 2017, filed 27 Apr 2017.